Adoptive transfer of protection to Taenia taeniaeformis infection in rats with immune spleen cells. 1994

K Asano, and A Ito, and K Ikeda, and K Okamoto
Department of Medical Biology, School of Medicine, Showa University, Tokyo, Japan.

The effector mechanism of the protection against re-infection with eggs of Taenia taeniaeformis was evaluated in rats by analysing protection dynamics against an ongoing primary infection. Immune spleen cells were prepared from F344 donor rats 10 days after oral inoculation with 200 eggs and used for adoptive transfer experiments. When F344 recipient rats were injected intravenously with immune spleen cells (2 x 10(8)) from 2 to 48 h after a primary egg inoculation, there was a statistically significant reduction in the number of metacestodes recovered at day 30 of the infection. The highest protection figures were obtained in rats given immune cells at 12 or 24 h of the primary infection. The maximum reduction induced with immune cells was 92% when they were injected at 12 h of the ongoing infection. It is strongly suggested that the vulnerable stage of the parasite damaged by immune spleen cells is the initial stage of infection (oncosphere and post-oncosphere stages in the liver within 2 days, especially between 12 and 24 h).

UI MeSH Term Description Entries
D008297 Male Males
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013047 Specific Pathogen-Free Organisms Animals or humans raised in the absence of a particular disease-causing virus or other microorganism. Less frequently plants are cultivated pathogen-free. Pathogen-Free Organisms,Specific Pathogen Free,Organism, Pathogen-Free,Organism, Specific Pathogen-Free,Organisms, Pathogen-Free,Organisms, Specific Pathogen-Free,Pathogen Free Organisms,Pathogen Free, Specific,Pathogen Frees, Specific,Pathogen-Free Organism,Pathogen-Free Organism, Specific,Pathogen-Free Organisms, Specific,Specific Pathogen Free Organisms,Specific Pathogen-Free Organism
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D013622 Taeniasis Infection with tapeworms of the genus Taenia. Taenia Infections,Taenia brauni Infection,Taenia glomeratus Infection,Taenia multiceps Infection,Taenia serialis Infection,Taenia solium Infection,Infections, Taenia,Infection, Taenia,Infection, Taenia brauni,Infection, Taenia glomeratus,Infection, Taenia multiceps,Infection, Taenia serialis,Infection, Taenia solium,Taenia Infection,Taenia brauni Infections,Taenia glomeratus Infections,Taenia multiceps Infections,Taenia serialis Infections,Taenia solium Infections,Taeniases
D016219 Immunotherapy, Adoptive Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314) Adoptive Cellular Immunotherapy,Adoptive Immunotherapy,CAR T-Cell Therapy,Cellular Immunotherapy, Adoptive,Chimeric Antigen Receptor Therapy,Immunotherapy, Adoptive Cellular,Adoptive Cellular Immunotherapies,Adoptive Immunotherapies,CAR T Cell Therapy,CAR T-Cell Therapies,Cellular Immunotherapies, Adoptive,Immunotherapies, Adoptive,Immunotherapies, Adoptive Cellular,T-Cell Therapies, CAR,T-Cell Therapy, CAR,Therapies, CAR T-Cell,Therapy, CAR T-Cell
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

K Asano, and A Ito, and K Ikeda, and K Okamoto
March 1980, Journal of helminthology,
K Asano, and A Ito, and K Ikeda, and K Okamoto
December 1968, The Australian journal of experimental biology and medical science,
K Asano, and A Ito, and K Ikeda, and K Okamoto
April 1985, International journal for parasitology,
K Asano, and A Ito, and K Ikeda, and K Okamoto
January 1983, Boletin chileno de parasitologia,
K Asano, and A Ito, and K Ikeda, and K Okamoto
April 1984, Avian pathology : journal of the W.V.P.A,
K Asano, and A Ito, and K Ikeda, and K Okamoto
March 1996, International archives of allergy and immunology,
K Asano, and A Ito, and K Ikeda, and K Okamoto
May 1980, Transplantation,
K Asano, and A Ito, and K Ikeda, and K Okamoto
June 1978, Journal of helminthology,
K Asano, and A Ito, and K Ikeda, and K Okamoto
March 1994, Journal of helminthology,
K Asano, and A Ito, and K Ikeda, and K Okamoto
January 1987, Parasitology research,
Copied contents to your clipboard!